GPX2 | Glutathione peroxidase 2 (gastrointestinal) | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GREM1 | Gremlin 1, DAN family BMP antagonist | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
GREM2 | Gremlin 2, DAN family BMP antagonist | Predicted secreted proteins
| | | | | Tissue enhanced |
IL11 | Interleukin 11 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
INHBA | Inhibin, beta A | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGBL1 | Integrin, beta-like 1 (with EGF-like repeat domains) | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KERA | Keratocan | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT222 | Keratin 222 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LCN2 | Lipocalin 2 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LGALS2 | Lectin, galactoside-binding, soluble, 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LIF | Leukemia inhibitory factor | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LUM | Lumican | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LYPD6 | LY6/PLAUR domain containing 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MMP1 | Matrix metallopeptidase 1 (interstitial collagenase) | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MMP19 | Matrix metallopeptidase 19 | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
MMP7 | Matrix metallopeptidase 7 (matrilysin, uterine) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC20 | Mucin 20, cell surface associated | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCMAP | Noncompact myelin associated protein | Predicted membrane proteins
| | | | | Tissue enhanced |
OGN | Osteoglycin | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OLFML2B | Olfactomedin-like 2B | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ONECUT1 | One cut homeobox 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ONECUT2 | One cut homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PCDHA4 | Protocadherin alpha 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
PLD1 | Phospholipase D1, phosphatidylcholine-specific | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
POU6F2 | POU class 6 homeobox 2 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PRDM6 | PR domain containing 6 | Enzymes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
RDH12 | Retinol dehydrogenase 12 (all-trans/9-cis/11-cis) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RNF183 | Ring finger protein 183 | Predicted membrane proteins
| | | | | Tissue enhanced |
SEMG1 | Semenogelin I | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINA4 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SFRP2 | Secreted frizzled-related protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
SLC1A7 | Solute carrier family 1 (glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A3 | Solute carrier family 28 (concentrative nucleoside transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC38A11 | Solute carrier family 38, member 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNAI1 | Snail family zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SULT1C4 | Sulfotransferase family, cytosolic, 1C, member 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SYT13 | Synaptotagmin XIII | Predicted intracellular proteins
| | | | | Tissue enhanced |
THBS2 | Thrombospondin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNFAIP6 | Tumor necrosis factor, alpha-induced protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TNFSF18 | Tumor necrosis factor (ligand) superfamily, member 18 | Predicted membrane proteins
| | | | | Tissue enhanced |
TPSAB1 | Tryptase alpha/beta 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TPSB2 | Tryptase beta 2 (gene/pseudogene) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
TSLP | Thymic stromal lymphopoietin | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ZPLD1 | Zona pellucida-like domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |